Vertex Pharmaceuticals Incorporated (BVMF:VRTX34)

Brazil · Delayed Price · Currency is BRL

618.38

0.00 (0.00%)

At close: Feb 6, 2026

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Trikafta / Kaftrio Revenue	10.46B	10.24B	8.94B
Trikafta / Kaftrio Revenue Growth	2.17%	14.47%	16.36%
Symdeko / Symkevi Revenue	-	-	123.00M
Symdeko / Symkevi Revenue Growth	-	-	-31.67%
Orkambi Revenue	-	-	326.00M
Orkambi Revenue Growth	-	-	-36.17%
Kalydeco Revenue	-	-	475.50M
Kalydeco Revenue Growth	-	-	-14.05%
Casgevy Revenue	69.50M	10.00M	-
Casgevy Revenue Growth	595.00%	-	-
Other Product Revenue	773.90M	781.50M	924.50M
Other Product Revenue Growth	-0.97%	-15.47%	-25.68%
Net Product Revenue	11.69B	11.02B	9.87B
Net Product Revenue Growth	6.10%	11.66%	10.51%
Revenue (Total)	11.69B	11.02B	9.87B
Revenue (Total) Growth	6.10%	11.66%	10.51%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
United States Product Revenue	7.29B	6.68B	6.04B
United States Product Revenue Growth	9.12%	10.67%	5.99%
Outside of United States Product Revenue	4.40B	4.34B	3.83B
Outside of United States Product Revenue Growth	1.45%	13.23%	18.49%
Revenue (Total)	11.69B	11.02B	9.87B
Revenue (Total) Growth	6.10%	11.66%	10.51%

Updated Sep 30, 2025. Data Source: Fiscal.ai.